Seokho Bryan Yoon's Net Worth
$77.7 Thousand
Who is Seokho Bryan Yoon?
Seokho Bryan Yoon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nightstar Therapeutics plc, LogicBio Therapeutics, Inc., and Terns Pharmaceuticals, Inc..
SEC CIK
Seokho Bryan Yoon's CIK is 0001761164
Past Insider Trading and Trends
2022 was Seokho Bryan Yoon's most active year for acquiring shares with 3 total transactions. Seokho Bryan Yoon's most active month to acquire stocks was the month of December. 2019 was Seokho Bryan Yoon's most active year for disposing of shares, totalling 3 transactions. Seokho Bryan Yoon's most active month to dispose stocks was the month of May. 2023 saw Seokho Bryan Yoon paying a total of $16,904.31 for 370,740 shares, this is the most they've acquired in one year. In 2019 Seokho Bryan Yoon cashed out on 260,100 shares for a total of $1,519,776.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nightstar Therapeutics plc No price found
General Counsel and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LogicBio Therapeutics, Inc. No price found
Chief Admin Officer & GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $5.755
COO and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.50% | 4.79K |
$4.44 | $21,272.04 | 91.94K |
May 31
| |||
Form 4
| +373.66% | 68.75K |
—
|
—
| 87.15K |
Jan 23
| |||
Form 4
| +4.21% | 743 |
$3.78 | $2,808.54 | 18.4K |
Nov 30
| |||
Form 4
| +130.53% | 10K |
$1.41 | $14,095.77 | 17.66K |
May 31
| |||
Form 4
| +0.04% | 3 |
$1.41 | $4.23 | 7.66K |
Nov 30 - Feb 1
| |||
Form 4
|
∞
| 7.66K |
$1.47 | $11,254.32 | 7.66K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||